NASDAQ: MBAVM3 Brigade Acquisition V Corp Stock
$10.80-0.02 (-0.18%)
Updated Jun 18, 2026
MBAV Price
$10.80
Fair Value Price
N/A
Market Cap
$388.13M
52 Week Low
$9.10
52 Week High
$13.39
P/E
83.08x
P/B
-19.04x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$4.58M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.05
Operating Cash Flow
-$3M
Beta
0.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MBAV Overview
M3-Brigade Acquisition V Corp. currently has no substantial commercial operations. Its central mission is to identify and complete a business combination with one or more existing enterprises, which could involve a merger, an exchange of shares, an asset acquisition, a stock purchase, or a corporate restructuring. This entity was established in 2024 and maintains its headquarters in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MBAV's potential to beat the market
- MBAV doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
MBAV
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $11.14 | C | |
| $12.57 | C |
Be the first to know about important MBAV news, forecast changes, insider trades & much more!
MBAV News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MBAV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MBAV was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MBAV is poor value based on its earnings relative to its share price (83.08x), compared to the US market average (9.47x)
P/E vs Market Valuation
MBAV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MBAV due diligence checks available for Premium users.
Valuation
MBAV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
83.08x
Industry
15.56x
Market
9.47x
MBAV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MBAV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MBAV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-19.04x
Industry
78.31x
MBAV's financial health
Profit margin
Revenue
$0.0
Net Income
$1.7M
Profit Margin
0%
MBAV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$310.6M
Liabilities
$21.4M
Debt to equity
-1.05
MBAV's short-term liabilities ($8.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MBAV's long-term liabilities ($13.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MBAV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MBAV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.4M
Investing
$0.0
Financing
$1.1M
MBAV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MBAV vs Shell Company Stocks
M3 Brigade Acquisition V Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.